Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Aymes International Limited

Clinicaltrial registered29 Oct 2026

Aymes International Limited

29 Oct 2026: Trial registered · Tolerance and Acceptability of an Oral Nutrition Supplement. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
29 Oct 2026
Title
Tolerance and Acceptability of an Oral Nutrition Supplement
Conditions
Disease Related Malnutrition
Phase
Not applicable
Study Type
Interventional
Status
Not Yet Recruiting
Countries
United Kingdom
Country
United Kingdom
Reference
NCT07904715
Location
United Kingdom
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Aymes International Limited

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from United Kingdom

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.